Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control
Identifieur interne : 007795 ( Istex/Corpus ); précédent : 007794; suivant : 007796Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control
Auteurs : A. Y. De Kanter ; A. N. Van Geel ; M. A. Paul ; C. H. J. Van Eijck ; S. C. Henzen-Logmans ; R. H. Kruyt ; E. P. Krenning ; A. M. M. Eggermont ; T. WiggersSource :
- European Journal of Surgical Oncology [ 0748-7983 ] ; 2000.
English descriptors
- KwdEn :
Abstract
Aims It is proposed that sentinel node biopsy should replace axillary lymph-node dissection. We analysed the role of a coordinator in the introduction of the sentinel node biopsy in breast cancer in a multi-centre setting to assure standardization and quality control. Methods We included 232 operable breast cancer patients. Part of the procedure was an ultrasound examination of the axilla with fine needle aspiration cytology. The sentinel node was identified with 99m-Technetium and Patent Blue. Results The results of the procedure, sensitivity and false negativity, were the same for the three participating hospitals. We think this is mostly due to the coordinator who supplied information about the technique, pitfalls and results to all teams. Conclusions Our experience regarding the organization aspects of introducing the sentinel node procedure in a multi-centre setting now serves as a model in organizing its application in a much wider number of hospitals.
Url:
DOI: 10.1053/ejso.2000.0976
Links to Exploration step
ISTEX:FF61AF320C37DA025BEEFABD5FAA2B997E79504DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</title><author><name sortKey="De Kanter, A Y" sort="De Kanter, A Y" uniqKey="De Kanter A" first="A. Y." last="De Kanter">A. Y. De Kanter</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Van Geel, A N" sort="Van Geel, A N" uniqKey="Van Geel A" first="A. N." last="Van Geel">A. N. Van Geel</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Paul, M A" sort="Paul, M A" uniqKey="Paul M" first="M. A." last="Paul">M. A. Paul</name><affiliation><mods:affiliation>Department of Nuclear Medicine, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Van Eijck, C H J" sort="Van Eijck, C H J" uniqKey="Van Eijck C" first="C. H. J." last="Van Eijck">C. H. J. Van Eijck</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Henzen Logmans, S C" sort="Henzen Logmans, S C" uniqKey="Henzen Logmans S" first="S. C." last="Henzen-Logmans">S. C. Henzen-Logmans</name><affiliation><mods:affiliation>Department of Pathology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Kruyt, R H" sort="Kruyt, R H" uniqKey="Kruyt R" first="R. H." last="Kruyt">R. H. Kruyt</name><affiliation><mods:affiliation>Department of Radiology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Krenning, E P" sort="Krenning, E P" uniqKey="Krenning E" first="E. P." last="Krenning">E. P. Krenning</name><affiliation><mods:affiliation>Department of Surgery, Zuiderziekenhuis Rotterdam, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A. M. M." last="Eggermont">A. M. M. Eggermont</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Wiggers, T" sort="Wiggers, T" uniqKey="Wiggers T" first="T." last="Wiggers">T. Wiggers</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:FF61AF320C37DA025BEEFABD5FAA2B997E79504D</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1053/ejso.2000.0976</idno><idno type="url">https://api.istex.fr/document/FF61AF320C37DA025BEEFABD5FAA2B997E79504D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">007795</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007795</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</title><author><name sortKey="De Kanter, A Y" sort="De Kanter, A Y" uniqKey="De Kanter A" first="A. Y." last="De Kanter">A. Y. De Kanter</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Van Geel, A N" sort="Van Geel, A N" uniqKey="Van Geel A" first="A. N." last="Van Geel">A. N. Van Geel</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Paul, M A" sort="Paul, M A" uniqKey="Paul M" first="M. A." last="Paul">M. A. Paul</name><affiliation><mods:affiliation>Department of Nuclear Medicine, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Van Eijck, C H J" sort="Van Eijck, C H J" uniqKey="Van Eijck C" first="C. H. J." last="Van Eijck">C. H. J. Van Eijck</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Henzen Logmans, S C" sort="Henzen Logmans, S C" uniqKey="Henzen Logmans S" first="S. C." last="Henzen-Logmans">S. C. Henzen-Logmans</name><affiliation><mods:affiliation>Department of Pathology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Kruyt, R H" sort="Kruyt, R H" uniqKey="Kruyt R" first="R. H." last="Kruyt">R. H. Kruyt</name><affiliation><mods:affiliation>Department of Radiology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Krenning, E P" sort="Krenning, E P" uniqKey="Krenning E" first="E. P." last="Krenning">E. P. Krenning</name><affiliation><mods:affiliation>Department of Surgery, Zuiderziekenhuis Rotterdam, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A. M. M." last="Eggermont">A. M. M. Eggermont</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Wiggers, T" sort="Wiggers, T" uniqKey="Wiggers T" first="T." last="Wiggers">T. Wiggers</name><affiliation><mods:affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Surgical Oncology</title><title level="j" type="abbrev">YEJSO</title><idno type="ISSN">0748-7983</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">26</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="652">652</biblScope><biblScope unit="page" to="656">656</biblScope></imprint><idno type="ISSN">0748-7983</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0748-7983</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>learning curve</term><term>quality control.</term><term>sentinel node</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Aims It is proposed that sentinel node biopsy should replace axillary lymph-node dissection. We analysed the role of a coordinator in the introduction of the sentinel node biopsy in breast cancer in a multi-centre setting to assure standardization and quality control. Methods We included 232 operable breast cancer patients. Part of the procedure was an ultrasound examination of the axilla with fine needle aspiration cytology. The sentinel node was identified with 99m-Technetium and Patent Blue. Results The results of the procedure, sensitivity and false negativity, were the same for the three participating hospitals. We think this is mostly due to the coordinator who supplied information about the technique, pitfalls and results to all teams. Conclusions Our experience regarding the organization aspects of introducing the sentinel node procedure in a multi-centre setting now serves as a model in organizing its application in a much wider number of hospitals.</div></front></TEI><istex><corpusName>elsevier</corpusName><keywords><teeft><json:string>node</json:string><json:string>axillary</json:string><json:string>breast cancer</json:string><json:string>alnd</json:string><json:string>sentinel node</json:string><json:string>lumpectomy</json:string><json:string>metastasis</json:string><json:string>ultrasound</json:string><json:string>tumour</json:string><json:string>sentinel node biopsy</json:string><json:string>surg</json:string><json:string>axilla</json:string><json:string>quality control</json:string><json:string>sentinel</json:string><json:string>biopsy</json:string><json:string>breast cancer patients</json:string><json:string>sentinel node procedure</json:string><json:string>standard procedure</json:string><json:string>cancer centre</json:string><json:string>lymph</json:string><json:string>university hospital</json:string><json:string>axillary lymph nodes</json:string><json:string>histological examination</json:string><json:string>diagnostic lumpectomy</json:string><json:string>sentinel nodes</json:string><json:string>needle aspiration cytology</json:string><json:string>study coordinator</json:string><json:string>standard treatment</json:string><json:string>same dose</json:string><json:string>nuclear medicine</json:string><json:string>ultrasound examination</json:string><json:string>complete alnd</json:string><json:string>harcourt publishers</json:string><json:string>multiple sections</json:string><json:string>immunohistochemical staining</json:string><json:string>radical mastectomy</json:string><json:string>axillary status</json:string><json:string>radioactive tracer</json:string><json:string>detection rate</json:string><json:string>full alnd</json:string><json:string>multiple sectioning</json:string><json:string>lymph node metastases</json:string><json:string>optimal procedure</json:string><json:string>surgical oncology</json:string><json:string>breast carcinoma</json:string><json:string>axillary lymph node metastases</json:string><json:string>surg oncol</json:string><json:string>arch surg</json:string><json:string>lymphatic mapping</json:string><json:string>site reviews</json:string></teeft></keywords><author><json:item><name>A.Y. de Kanter</name><affiliations><json:string>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</json:string></affiliations></json:item><json:item><name>A.N. van Geel</name><affiliations><json:string>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</json:string></affiliations></json:item><json:item><name>M.A. Paul</name><affiliations><json:string>Department of Nuclear Medicine, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</json:string></affiliations></json:item><json:item><name>C.H.J. van Eijck</name><affiliations><json:string>Department of Surgery, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</json:string></affiliations></json:item><json:item><name>S.C. Henzen-Logmans</name><affiliations><json:string>Department of Pathology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</json:string></affiliations></json:item><json:item><name>R.H. Kruyt</name><affiliations><json:string>Department of Radiology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</json:string></affiliations></json:item><json:item><name>E.P. Krenning</name><affiliations><json:string>Department of Surgery, Zuiderziekenhuis Rotterdam, The Netherlands</json:string></affiliations></json:item><json:item><name>A.M.M. Eggermont</name><affiliations><json:string>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</json:string></affiliations></json:item><json:item><name>T. Wiggers</name><affiliations><json:string>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>sentinel node</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>learning curve</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>quality control.</value></json:item></subject><language><json:string>eng</json:string></language><originalGenre><json:string>Full-length article</json:string></originalGenre><abstract>Aims It is proposed that sentinel node biopsy should replace axillary lymph-node dissection. We analysed the role of a coordinator in the introduction of the sentinel node biopsy in breast cancer in a multi-centre setting to assure standardization and quality control. Methods We included 232 operable breast cancer patients. Part of the procedure was an ultrasound examination of the axilla with fine needle aspiration cytology. The sentinel node was identified with 99m-Technetium and Patent Blue. Results The results of the procedure, sensitivity and false negativity, were the same for the three participating hospitals. We think this is mostly due to the coordinator who supplied information about the technique, pitfalls and results to all teams. Conclusions Our experience regarding the organization aspects of introducing the sentinel node procedure in a multi-centre setting now serves as a model in organizing its application in a much wider number of hospitals.</abstract><qualityIndicators><score>5.244</score><pdfVersion>1.3</pdfVersion><pdfPageSize>595 x 842 pts (A4)</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>3</keywordCount><abstractCharCount>972</abstractCharCount><pdfWordCount>3480</pdfWordCount><pdfCharCount>21455</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>147</abstractWordCount></qualityIndicators><title>Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</title><pii><json:string>S0748-7983(00)90976-4</json:string></pii><genre><json:string>research-article</json:string></genre><host><title>European Journal of Surgical Oncology</title><language><json:string>unknown</json:string></language><publicationDate>2000</publicationDate><issn><json:string>0748-7983</json:string></issn><pii><json:string>S0748-7983(00)X0011-X</json:string></pii><volume>26</volume><issue>7</issue><pages><first>652</first><last>656</last></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>surgery</json:string><json:string>oncology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>oncology & carcinogenesis</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>2000</publicationDate><copyrightDate>2000</copyrightDate><doi><json:string>10.1053/ejso.2000.0976</json:string></doi><id>FF61AF320C37DA025BEEFABD5FAA2B997E79504D</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/FF61AF320C37DA025BEEFABD5FAA2B997E79504D/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/FF61AF320C37DA025BEEFABD5FAA2B997E79504D/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/FF61AF320C37DA025BEEFABD5FAA2B997E79504D/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>©2000 Harcourt Publishers Ltd</p></availability><date>2000</date></publicationStmt><notesStmt><note>Correspondence to: A. Y. de Kanter, C/O Department of Surgical Oncology, University Hospital Rotterdam/Daniel, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel: +31-10-4391506.</note><note type="content">Section title: Regular Article</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</title><author xml:id="author-0000"><persName><forename type="first">A.Y.</forename><surname>de Kanter</surname></persName><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation></author><author xml:id="author-0001"><persName><forename type="first">A.N.</forename><surname>van Geel</surname></persName><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation></author><author xml:id="author-0002"><persName><forename type="first">M.A.</forename><surname>Paul</surname></persName><affiliation>Department of Nuclear Medicine, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</affiliation></author><author xml:id="author-0003"><persName><forename type="first">C.H.J.</forename><surname>van Eijck</surname></persName><affiliation>Department of Surgery, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</affiliation></author><author xml:id="author-0004"><persName><forename type="first">S.C.</forename><surname>Henzen-Logmans</surname></persName><affiliation>Department of Pathology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation></author><author xml:id="author-0005"><persName><forename type="first">R.H.</forename><surname>Kruyt</surname></persName><affiliation>Department of Radiology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation></author><author xml:id="author-0006"><persName><forename type="first">E.P.</forename><surname>Krenning</surname></persName><affiliation>Department of Surgery, Zuiderziekenhuis Rotterdam, The Netherlands</affiliation></author><author xml:id="author-0007"><persName><forename type="first">A.M.M.</forename><surname>Eggermont</surname></persName><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation></author><author xml:id="author-0008"><persName><forename type="first">T.</forename><surname>Wiggers</surname></persName><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation></author><idno type="istex">FF61AF320C37DA025BEEFABD5FAA2B997E79504D</idno><idno type="DOI">10.1053/ejso.2000.0976</idno><idno type="PII">S0748-7983(00)90976-4</idno></analytic><monogr><title level="j">European Journal of Surgical Oncology</title><title level="j" type="abbrev">YEJSO</title><idno type="pISSN">0748-7983</idno><idno type="PII">S0748-7983(00)X0011-X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000"></date><biblScope unit="volume">26</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="652">652</biblScope><biblScope unit="page" to="656">656</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2000</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Aims It is proposed that sentinel node biopsy should replace axillary lymph-node dissection. We analysed the role of a coordinator in the introduction of the sentinel node biopsy in breast cancer in a multi-centre setting to assure standardization and quality control. Methods We included 232 operable breast cancer patients. Part of the procedure was an ultrasound examination of the axilla with fine needle aspiration cytology. The sentinel node was identified with 99m-Technetium and Patent Blue. Results The results of the procedure, sensitivity and false negativity, were the same for the three participating hospitals. We think this is mostly due to the coordinator who supplied information about the technique, pitfalls and results to all teams. Conclusions Our experience regarding the organization aspects of introducing the sentinel node procedure in a multi-centre setting now serves as a model in organizing its application in a much wider number of hospitals.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>sentinel node</term></item><item><term>learning curve</term></item><item><term>quality control.</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2000">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/FF61AF320C37DA025BEEFABD5FAA2B997E79504D/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="fla" xml:lang="en"><item-info><jid>YEJSO</jid><aid>90976</aid><ce:pii>S0748-7983(00)90976-4</ce:pii><ce:doi>10.1053/ejso.2000.0976</ce:doi><ce:copyright type="full-transfer" year="2000">Harcourt Publishers Ltd</ce:copyright></item-info><head><ce:article-footnote><ce:label>☆</ce:label><ce:note-para>Correspondence to: A. Y. de Kanter, C/O Department of Surgical Oncology, University Hospital Rotterdam/Daniel, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel: +31-10-4391506.</ce:note-para></ce:article-footnote><ce:dochead><ce:textfn>Regular Article</ce:textfn></ce:dochead><ce:title>Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</ce:title><ce:author-group><ce:author><ce:given-name>A.Y.</ce:given-name><ce:surname>de Kanter</ce:surname><ce:cross-ref refid="A1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>A.N.</ce:given-name><ce:surname>van Geel</ce:surname><ce:cross-ref refid="A1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>M.A.</ce:given-name><ce:surname>Paul</ce:surname><ce:cross-ref refid="A6"><ce:sup>b</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>C.H.J.</ce:given-name><ce:surname>van Eijck</ce:surname><ce:cross-ref refid="A5"><ce:sup>c</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>S.C.</ce:given-name><ce:surname>Henzen-Logmans</ce:surname><ce:cross-ref refid="A2"><ce:sup>d</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>R.H.</ce:given-name><ce:surname>Kruyt</ce:surname><ce:cross-ref refid="A3"><ce:sup>e</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>E.P.</ce:given-name><ce:surname>Krenning</ce:surname><ce:cross-ref refid="A4"><ce:sup>f</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>A.M.M.</ce:given-name><ce:surname>Eggermont</ce:surname><ce:cross-ref refid="A1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>T.</ce:given-name><ce:surname>Wiggers</ce:surname><ce:cross-ref refid="A1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="A1"><ce:label>a</ce:label><ce:textfn>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</ce:textfn></ce:affiliation><ce:affiliation id="A2"><ce:label>d</ce:label><ce:textfn>Department of Pathology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</ce:textfn></ce:affiliation><ce:affiliation id="A3"><ce:label>e</ce:label><ce:textfn>Department of Radiology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</ce:textfn></ce:affiliation><ce:affiliation id="A4"><ce:label>f</ce:label><ce:textfn>Department of Surgery, Zuiderziekenhuis Rotterdam, The Netherlands</ce:textfn></ce:affiliation><ce:affiliation id="A5"><ce:label>c</ce:label><ce:textfn>Department of Surgery, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</ce:textfn></ce:affiliation><ce:affiliation id="A6"><ce:label>b</ce:label><ce:textfn>Department of Nuclear Medicine, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</ce:textfn></ce:affiliation></ce:author-group><ce:date-accepted day="19" month="5" year="2000"></ce:date-accepted><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para><ce:bold>Aims</ce:bold> It is proposed that sentinel node biopsy should replace axillary lymph-node dissection. We analysed the role of a coordinator in the introduction of the sentinel node biopsy in breast cancer in a multi-centre setting to assure standardization and quality control. <ce:bold>Methods</ce:bold> We included 232 operable breast cancer patients. Part of the procedure was an ultrasound examination of the axilla with fine needle aspiration cytology. The sentinel node was identified with 99m-Technetium and Patent Blue. <ce:bold>Results</ce:bold> The results of the procedure, sensitivity and false negativity, were the same for the three participating hospitals. We think this is mostly due to the coordinator who supplied information about the technique, pitfalls and results to all teams. <ce:bold>Conclusions</ce:bold> Our experience regarding the organization aspects of introducing the sentinel node procedure in a multi-centre setting now serves as a model in organizing its application in a much wider number of hospitals.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>sentinel node</ce:text></ce:keyword><ce:keyword><ce:text>learning curve</ce:text></ce:keyword><ce:keyword><ce:text>quality control.</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control</title></titleInfo><name type="personal"><namePart type="given">A.Y.</namePart><namePart type="family">de Kanter</namePart><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.N.</namePart><namePart type="family">van Geel</namePart><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.A.</namePart><namePart type="family">Paul</namePart><affiliation>Department of Nuclear Medicine, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.H.J.</namePart><namePart type="family">van Eijck</namePart><affiliation>Department of Surgery, University Hospital Rotterdam/Dijkzigt Hospital, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.C.</namePart><namePart type="family">Henzen-Logmans</namePart><affiliation>Department of Pathology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Kruyt</namePart><affiliation>Department of Radiology, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.P.</namePart><namePart type="family">Krenning</namePart><affiliation>Department of Surgery, Zuiderziekenhuis Rotterdam, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.M.M.</namePart><namePart type="family">Eggermont</namePart><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Wiggers</namePart><affiliation>Department of Surgery, University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">2000</dateIssued><copyrightDate encoding="w3cdtf">2000</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Aims It is proposed that sentinel node biopsy should replace axillary lymph-node dissection. We analysed the role of a coordinator in the introduction of the sentinel node biopsy in breast cancer in a multi-centre setting to assure standardization and quality control. Methods We included 232 operable breast cancer patients. Part of the procedure was an ultrasound examination of the axilla with fine needle aspiration cytology. The sentinel node was identified with 99m-Technetium and Patent Blue. Results The results of the procedure, sensitivity and false negativity, were the same for the three participating hospitals. We think this is mostly due to the coordinator who supplied information about the technique, pitfalls and results to all teams. Conclusions Our experience regarding the organization aspects of introducing the sentinel node procedure in a multi-centre setting now serves as a model in organizing its application in a much wider number of hospitals.</abstract><note>Correspondence to: A. Y. de Kanter, C/O Department of Surgical Oncology, University Hospital Rotterdam/Daniel, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel: +31-10-4391506.</note><note type="content">Section title: Regular Article</note><subject lang="en"><genre>Keywords</genre><topic>sentinel node</topic><topic>learning curve</topic><topic>quality control.</topic></subject><relatedItem type="host"><titleInfo><title>European Journal of Surgical Oncology</title></titleInfo><titleInfo type="abbreviated"><title>YEJSO</title></titleInfo><genre type="journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">200011</dateIssued></originInfo><identifier type="ISSN">0748-7983</identifier><identifier type="PII">S0748-7983(00)X0011-X</identifier><part><date>200011</date><detail type="volume"><number>26</number><caption>vol.</caption></detail><detail type="issue"><number>7</number><caption>no.</caption></detail><extent unit="issue pages"><start>635</start><end>724</end></extent><extent unit="pages"><start>652</start><end>656</end></extent></part></relatedItem><identifier type="istex">FF61AF320C37DA025BEEFABD5FAA2B997E79504D</identifier><identifier type="DOI">10.1053/ejso.2000.0976</identifier><identifier type="PII">S0748-7983(00)90976-4</identifier><accessCondition type="use and reproduction" contentType="copyright">©2000 Harcourt Publishers Ltd</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>Harcourt Publishers Ltd, ©2000</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007795 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 007795 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:FF61AF320C37DA025BEEFABD5FAA2B997E79504D
|texte= Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control
}}
| This area was generated with Dilib version V0.6.31. |  |